| 标题 |
专利、报告等 A phase 2 multicenter, open-label, randomized, controlled trial in patients with stage II/III colorectal cancer who are ctDNA positive following resection to compare efficacy of autogene cevumeran versus watchful waiting |
| 备注 |
求ASCO 2022 TPS3641完整poster原件,Kopetz等,BNT122-01/NCT04486378试验设计;不是一页会议摘要。摘要DOI仅用于定位:10.1200/JCO.2022.40.16_suppl.TPS3641。
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)